Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea
Abstract BACKGROUND Choline alfoscerate, a cholinergic precursor, is widely used in Korea for dementia‐related symptoms and is covered by national health insurance (NHI). This study investigates the utilization trends and factors influencing choline alfoscerate prescription in newly diagnosed Alzhei...
Saved in:
| Main Authors: | Yeon Hee Kim, Nakyung Jeon, Nam Kyung Je |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.70019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience in using ceretone (choline alfoscerate) in brain concussion
by: N. G. Voropay, et al.
Published: (2010-12-01) -
Therapeutic correction of cognitive disorders of various etiologies: a report from the 20th anniversary congress "Veinovskie Chtenia"
by: M. P. Verminsky
Published: (2024-04-01) -
In Silico and In Vivo Evaluation of a New Derivative from Memantine and Sinapic Acid (<i>N</i>-Sinapoyl-memantine) as a Candidate for the Management of Alzheimer’s Disease
by: Andrey Popatanasov, et al.
Published: (2025-05-01) -
Choline preparations in the treatment of asthenic states: modernity and perspectives (A Clinical Case Presentation)
by: Yu. V. Bykov, et al.
Published: (2022-12-01) -
Are antidementia drugs associated with reduced mortality after a hospital emergency admission in the population with dementia aged 65 years and older?
by: Simona Hapca, et al.
Published: (2019-01-01)